Increased exposure to glyphosate, one of the most widely used herbicides in the United States and much of the world, harms infant health in U.S. agricultural counties, according to a new study by two University of Oregon economists.
Sarepta, Arrowhead Pharmaceuticals partner to advance RNA-based drugs in rare diseases
Sarepta Therapeutics said Tuesday that it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of experimental RNA-based drugs to treat rare diseases
November 26, 2024